Linden Thomas Advisory Services’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Linden Thomas Advisory Services's HALO Position: Q3 2026 in Review
Linden Thomas Advisory Services increased its Halozyme (HALO) stake by 1.1% in Q3 2026, buying an estimated $28.6K and bringing the position to 27,774 shares worth $3.07M. The position accounts for 0.24% of the portfolio, ranked #122.
Linden Thomas Advisory Services first reported a position in HALO in Q4 2022 and has held it in 16 quarters since. 249 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Linden Thomas Advisory Services held 27,774 shares of Halozyme worth $3.07M as of Q3 2026.
- Linden Thomas Advisory Services bought 296 Halozyme shares in Q3 2026, an estimated $28.6K.
- Halozyme made up 0.24% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #122 holding.
- Linden Thomas Advisory Services first reported a position in Halozyme in Q4 2022 and has held it in 16 quarters since.
- 249 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.